Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Sep 2025 is -2.96% vs 0.55% in Sep 2024
Consolidate Net Profit
YoY Growth in quarter ended Sep 2025 is 4.89% vs -7.30% in Sep 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Sep 2025 is -35.52% vs -9.71% in Sep 2024
Interest
YoY Growth in quarter ended Sep 2025 is 148.39% vs -11.43% in Sep 2024
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Sep 2025 has improved from Sep 2024
Compare Quarterly Results Of China Resources Double-Crane Pharmaceutical Co., Ltd. With
Quarterly - Net Sales
QoQ Growth in quarter ended Sep 2025 is -4.55% vs -13.51% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -2.96% vs 0.55% in Sep 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Sep 2025 is -23.30% vs -6.29% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 4.89% vs -7.30% in Sep 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Sep 2025 is -50.52% vs -10.33% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -35.52% vs -9.71% in Sep 2024
Quarterly - Interest
QoQ Growth in quarter ended Sep 2025 is -7.23% vs -3.49% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 148.39% vs -11.43% in Sep 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2025 has fallen from Jun 2025
YoY Growth in quarter ended Sep 2025 has improved from Sep 2024






